Jianming Xu

Director of In Vivo Pharmacology GemPharmatech

Seminars

Thursday 11th June 2026
In Vitro & In Vivo Preclinical Evaluation of Antibody-Drug Conjugates
11:00 am
  • Explore how in vitro assays can facilitate lead candidate selection through pharmacodynamic analysis
  • Discuss how to evaluate the bystander effect of ADCs using in vivo mouse models, and how model selection impacts the pharmacokinetic profile of ADCs
  • Showcase how in vivo mouse models can reveal clinically relevant drug resistance mechanisms to Enhertu
Jianming Xu - Speaker